{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06120400",
            "orgStudyIdInfo": {
                "id": "HDE"
            },
            "organization": {
                "fullName": "Penn State University",
                "class": "OTHER"
            },
            "briefTitle": "Cardiovascular Effects of a Healthy Dietary Pattern Containing Eggs",
            "officialTitle": "Cardiovascular Effects of a Healthy Dietary Pattern Containing Eggs: a Controlled-feeding Study",
            "therapeuticArea": [
                "Other"
            ],
            "study": "cardiovascular-effects-of-a-healthy-dietary-pattern-containing-eggs"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-25",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-11-02",
            "studyFirstSubmitQcDate": "2023-11-02",
            "studyFirstPostDateStruct": {
                "date": "2023-11-07",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-31",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-04",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Kristina Petersen PhD, APD, FAHA",
                "investigatorTitle": "Associate Professor",
                "investigatorAffiliation": "Penn State University"
            },
            "leadSponsor": {
                "name": "Penn State University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "American Egg Board",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will examine the effect of a healthy diet containing 2 eggs per day compared to a healthy diet containing 3 eggs per week on biomarkers of heart health after 4 weeks.",
            "detailedDescription": "This is a 2-period, randomized, crossover, controlled feeding study examining the effect of 2020-2025 Dietary Guidelines for Americans adherent dietary patterns containing 2 eggs/day/2000 kcal (HD+E) compared to 3 eggs/week/2000 kcal (HD) on biomarkers of cardiovascular health and function after 4 weeks."
        },
        "conditionsModule": {
            "conditions": [
                "Cardiovascular Diseases"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 65,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Healthy Diet + Eggs (HD+E)",
                    "type": "EXPERIMENTAL",
                    "description": "2020-2025 Dietary Guidelines for Americans adherent dietary pattern containing 2 eggs/day/2000 kcal",
                    "interventionNames": [
                        "Drug: Whole Egg"
                    ]
                },
                {
                    "label": "Healthy Diet (HD)",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "2020-2025 Dietary Guidelines for Americans adherent dietary pattern containing 3 eggs/week/2000 kcal (HD)",
                    "interventionNames": [
                        "Drug: Whole Egg"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Whole Egg",
                    "description": "Whole Large, Grade A Egg",
                    "armGroupLabels": [
                        "Healthy Diet (HD)",
                        "Healthy Diet + Eggs (HD+E)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "LDL-cholesterol change",
                    "description": "Assessed from fasting blood draw expressed in mg/dL. LDL-cholesterol will be measured directly via enzymatic assay. Change in LDL-cholesterol will be calculated as the mean of the end of diet measures (i.e., mean of day 1 and day 2 values) minus the mean of the baseline measures (i.e., mean of day 1 and day 2 values).",
                    "timeFrame": "4 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Triglyceride change",
                    "description": "Assessed from fasting blood draw expressed in mg/dL.",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Total cholesterol change",
                    "description": "Assessed from fasting blood draw expressed in mg/dL.",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "HDL-cholesterol change",
                    "description": "Assessed from fasting blood draw expressed in mg/dL.",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "LDL-cholesterol to HDL-cholesterol ratio change",
                    "description": "LDL-cholesterol and HDL-cholesterol will be measured from a fasting blood draw expressed in mg/dL. The ratio will be calculated as LDL-C divided by HDL-C",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Change in particle size and number of LDL, HDL, VLDL and chylomicrons",
                    "description": "Measured via Nuclear Magnetic Resonance",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Change in central systolic and diastolic blood pressure",
                    "description": "Blood pressure measured assessed using a SphymoCor Xcel (Atcor Medical)",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Change in brachial systolic and diastolic blood pressure",
                    "description": "Blood pressure measured assessed using a SphymoCor Xcel (Atcor Medical)",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Change in fasting serum insulin",
                    "description": "Serum insulin levels assessed in a fasting blood draw and expressed in micro IU/ml",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Change in fasting plasma glucose concentration",
                    "description": "Glucose assessed in a fasting blood draw and expressed in mg/dL",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Change in Fructosamine",
                    "description": "Fructosamine assess in a fasting blood draw and expressed in micro IU/ml",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Change in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)",
                    "description": "Calculated from insulin and glucose measured from a fasting blood sample. Calculated as (insulin \u00d7 glucose) / 22.5",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Change in carotid-femoral pulse wave velocity",
                    "description": "A measure of arterial stiffness assessed using a SphymoCor Xcel (Atcor Medical). Expressed in meters/second.",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Change in trimethylamine N-oxide (TMAO)",
                    "description": "Measured in fasting blood. Expressed as \u00b5mol/L",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Change in choline",
                    "description": "Measured in fasting blood. Expressed as \u00b5mol/L",
                    "timeFrame": "4 weeks"
                },
                {
                    "measure": "Change in carnitine",
                    "description": "Measured in fasting blood. Expressed as \u00b5mol/L",
                    "timeFrame": "4 weeks"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Change in the composition of the gut microbiota",
                    "description": "Abundance measured using 16 s rRNA sequencing",
                    "timeFrame": "4 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* LDL-C \u2265115 mg/dL and \u2264190 mg/L\n* BMI of 25-35 kg/m2\n* Intake of \\<14 eggs/week for the prior 3 months\n* Blood pressure \\<140/90 mmHg\n* Fasting blood glucose \\<126 mg/dL\n* Fasting triglycerides \\<350 mg/dL\n* \u226410% change in body weight in the prior 6 months\n\nExclusion Criteria:\n\n* Type 1 or type 2 diabetes or fasting blood glucose \u2265126 mg/dL\n* Prescription of anti-hypertensive, lipid lowering or glucose lowering drugs\n* Intake of supplements that affect the outcomes of interest and unwilling to cease during the study period\n* Diagnosed liver, kidney, or autoimmune disease\n* Prior cardiovascular event (e.g., stroke, heart attack)\n* Current pregnancy or intention of pregnancy within the next 6 months\n* Lactation within prior 6 months\n* Follows a vegetarian or vegan diet\n* Food allergies/intolerance/sensitives/dislikes of foods included in the study menu\n* Antibiotic use within the prior 1 month\n* Oral steroid use within the prior 1 month\n* Use of tobacco or nicotine containing products with in the past 6 months\n* Cancer any site within the past 10 years (eligible if \u226510 years without recurrence) or non-melanoma skin cancer with in the past 5 years (eligible if \u22655 years without recurrence)\n* Participation in another clinical trial within 30 days of baseline\n* Currently following a restricted or weight loss diet\n* Prior bariatric surgery\n* Intake of \\>14 alcoholic drinks/week and/or lack of willingness to consume a maximum of two standard drinks per week while enrolled in the study and/or not willing to avoid alcohol consumption for 48 hour prior to test visits",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "30 Years",
            "maximumAge": "60 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Kristina Petersen, PhD",
                    "role": "CONTACT",
                    "phone": "814-865-7206",
                    "email": "kup63@psu.edu"
                },
                {
                    "name": "Stacey Meily",
                    "role": "CONTACT",
                    "phone": "814-863-8622",
                    "email": "sas117@psu.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Kristina Petersen",
                    "affiliation": "The Pennsylvania State University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "The Pennylvania State University",
                    "status": "RECRUITING",
                    "city": "University Park",
                    "state": "Pennsylvania",
                    "zip": "16802",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "phone": "866-778-3438",
                            "email": "DCHLab@psu.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.80201,
                        "lon": -77.85639
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "De-identified individual participant data will be deposited into an open access repository once results from all pre-specified primary and secondary outcomes are published.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "ANALYTIC_CODE"
            ],
            "timeFrame": "After publication of all pre-specified primary and secondary outcomes"
        }
    },
    "documentSection": {
        "largeDocumentModule": {
            "largeDocs": [
                {
                    "typeAbbrev": "SAP",
                    "hasProtocol": false,
                    "hasSap": true,
                    "hasIcf": false,
                    "label": "Statistical Analysis Plan",
                    "date": "2024-04-11",
                    "uploadDate": "2024-04-11T16:07",
                    "filename": "SAP_000.pdf",
                    "size": 369429
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                }
            ]
        }
    },
    "hasResults": false
}